Biodexa Pharmaceuticals Plc is a drug delivery technology company. The company is headquartered in Abingdon, Oxfordshire and currently employs 13 full-time employees. The company went IPO on 2014-12-08. The firm is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.
How did BDRX's recent EPS compare to expectations?
The most recent EPS for Biodexa Pharmaceuticals PLC is $, expectations of $.
How did Biodexa Pharmaceuticals PLC BDRX's revenue perform in the last quarter?
Biodexa Pharmaceuticals PLC revenue for the last quarter is $
What is the revenue estimate for Biodexa Pharmaceuticals PLC?
According to of Wall street analyst, the revenue estimate of Biodexa Pharmaceuticals PLC range from $ to $
What's the earning quality score for Biodexa Pharmaceuticals PLC?
Biodexa Pharmaceuticals PLC has a earning quality score of B+/53.812656. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Biodexa Pharmaceuticals PLC report earnings?
Biodexa Pharmaceuticals PLC next earnings report is expected in 2025-12-11
What are Biodexa Pharmaceuticals PLC's expected earnings?
Biodexa Pharmaceuticals PLC expected earnings is $, according to wall-street analysts.
Did Biodexa Pharmaceuticals PLC beat earnings expectations?
Biodexa Pharmaceuticals PLC recent earnings of $ expectations.
